Risk of injurious road traffic crash after prescription of antidepressants

Background Antidepressants are commonly used worldwide. Experimental studies have suggested that antidepressants may impair driving abilities. Aims/Objectives/Purpose The study aims to estimate the risk of road traffic crash associated with prescription of antidepressants. Methods Data from three Fr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Injury prevention 2012-10, Vol.18 (Suppl 1), p.A187-A187
Hauptverfasser: Lagarde, E, Queinec, R, Philip, P, Gadegbeku, B, Delorme, B, Moore, N, Suissa, S, Salmi, L -R, Orriols, L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Antidepressants are commonly used worldwide. Experimental studies have suggested that antidepressants may impair driving abilities. Aims/Objectives/Purpose The study aims to estimate the risk of road traffic crash associated with prescription of antidepressants. Methods Data from three French national databases were extracted and matched: the national health care insurance database, police reports, and the national police database of injurious crashes. A case-control analysis comparing 34 896 responsible versus 37 789 non-responsible drivers was conducted. Case-crossover analysis was performed to investigate the acute effect of medicine exposure. Results/Outcomes 72 685 drivers identified by their national healthcare number, involved in an injurious crash in France over the July 2005 to May 2008 period, were included. 2936 drivers (4.0%) were exposed to at least one antidepressant on the day of the crash. The results showed a significant association between the risk of being responsible for a crash and prescription of antidepressants (OR=1.34 (1.22 to 1.47)). The case-crossover analysis showed no association with treatment prescription but the risk of road traffic crash increased after an initiation of an antidepressant treatment (OR=1.49 (1.24 to 1.79)) and after a change in antidepressant treatment (OR=1.32 (1.09 to 1.60)). Significance/Contribution to the Field Patients and prescribers should be warned about the risk of crash during periods of antidepressant medication and particularly high vulnerability periods such as those when a treatment is initiated or modified.
ISSN:1353-8047
1475-5785
DOI:10.1136/injuryprev-2012-040590r.3